Overview
Description
THC Biomed International Ltd. is a Canadian company operating within the cannabis sector. It focuses on the production, cultivation, and research of medical marijuana, aimed at providing high-quality cannabis products to patients and consumers. As one of the pioneers in the industry, THC Biomed is noted for its commitment to developing innovative technologies and strains to enhance the therapeutic properties and efficacy of cannabis products. Operating a combination of advanced growing facilities, THC Biomed ensures a consistent supply while adhering to rigorous quality control standards.
This company plays a significant role in the medical cannabis market by catering to both local demand and expanding into new markets, contributing to the broader societal shift towards legalization and acceptance of cannabis for medicinal purposes. Furthermore, THC Biomed engages in research to improve cultivation methods and product development, positioning itself at the forefront of marijuana innovation. As the legal landscape around marijuana continues to evolve, THC Biomed International Ltd.'s operations and research initiatives serve as a crucial component in shaping the future of medical cannabis offerings in the market.
About
CEO
Mr. John Miller
Employees
35
Address
2550 Acland Road
Unit 1
Kelowna, V1X 7L4, BC
Canada
Unit 1
Kelowna, V1X 7L4, BC
Canada
Phone
—
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Country
Germany
MIC code
XMUN